Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
North America leads with 50.14% share in 2024, supported by high diabetes prevalence and advanced treatment adoption
Randomized placebo controlled study on intravenous L-carnitine supplementation in hemodialysis patients-No benefit in vivo magnetic resonance spectroscopic assessment of muscle [abstract]
Seminars in Hearing, 40(4), 315326
The evidence record remains much narrower than the evidence supporting established medicines
Understanding your genetic predispositionsincluding variants in GIPR and FTOhelps PlexusDx providers tailor a plan that reduces the need for stopping or switching medications abruptly
US$ 27.74
US$ 26.78
US$ 23.77
US$ 22.64
US$ 22.66
